News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Koenig Scott
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/30/2023 |
4
| Koenig Scott (Director) has filed a Form 4 on GLYCOMIMETICS INC
Txns:
| Exercised 10,500 options to buy
@ $2.55, valued at
$26.8k
|
|
12/01/2022 |
4
| Koenig Scott (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Unknown transaction of 34,246 shares
@ $0 Disposed/sold 14,285 options to buy
@ $4.9, valued at
$70k
Disposed/sold 9,375 options to buy
@ $12, valued at
$112.5k
Disposed/sold 4,688 options to buy
@ $20.83, valued at
$97.7k
Disposed/sold 6,200 options to buy
@ $16.06, valued at
$99.6k
Disposed/sold 8,000 options to buy
@ $7.75, valued at
$62k
Disposed/sold 10,000 options to buy
@ $4.25, valued at
$42.5k
Disposed/sold 10,000 options to buy
@ $6.9, valued at
$69k
Disposed/sold 10,000 options to buy
@ $3.02, valued at
$30.2k
Disposed/sold 12,000 options to buy
@ $4.72, valued at
$56.6k
Disposed/sold 14,000 options to buy
@ $2.17, valued at
$30.4k
|
|
05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/18/2020 |
4
| Koenig Scott (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Granted 12,000 options to buy
@ $4.72, valued at
$56.6k
|
|
05/27/2020 |
4
| Koenig Scott (Director) has filed a Form 4 on GLYCOMIMETICS INC
Txns:
| Granted 21,000 options to buy
@ $3, valued at
$63k
|
|
03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/06/2019 |
4
| Koenig Scott (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Granted 10,000 options to buy
@ $3.02, valued at
$30.2k
|
|
05/30/2019 |
4
| Koenig Scott (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Exercised 32,018 options to buy
@ $0.35, valued at
$11.2k
|
|
05/21/2019 |
4
| Koenig Scott (Director) has filed a Form 4 on GLYCOMIMETICS INC
Txns:
| Granted 21,000 options to buy
@ $12.39, valued at
$260.2k
|
|
02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2019 |
4
| Koenig Scott (President and CEO) has filed a Form 4 on MACROGENICS INC
Txns:
| Exercised 39,897 options to buy
@ $0.94, valued at
$37.5k
|
|
11/19/2018 |
4
| Koenig Scott (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Granted 10,000 options to buy
@ $6.9, valued at
$69k
|
|
11/14/2018 |
4
| Koenig Scott (President and CEO) has filed a Form 4 on MACROGENICS INC
Txns:
| Exercised 40,000 options to buy
@ $0.94, valued at
$37.6k
|
|
07/27/2018 |
4
| Koenig Scott (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns:
| Granted 8,000 options to buy
@ $4.25, valued at
$34k
|
|
05/21/2018 |
4
| Koenig Scott (Director) has filed a Form 4 on GLYCOMIMETICS INC
Txns:
| Granted 11,000 options to buy
@ $18.41, valued at
$202.5k
|
|
03/06/2018 |
4
| Koenig Scott (President and CEO) has filed a Form 4 on MACROGENICS INC
Txns:
| Granted 225,000 options to buy
@ $28.94, valued at
$6.5M
|
|
05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/11/2013 |
4
| Koenig Scott (President and CEO) has filed a Form 4 on MACROGENICS INC
Txns:
| Granted 152,525 options to buy
@ $16, valued at
$2.4M
|
|
|
|